Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 37
4
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

Do you really need more protein if you exercise?

Protein is often thought to be a workout necessity, the essential complement to every gym bag. Missing protein...

Are cryptic characteristics preventing the protection of two similar Sphingidae moths?

This project is aimed at understanding the morphological differences between two species of Sphingidae...

Why be social? The costs and benefits of sociality in spiders

Sociality in spiders is extremely rare, but it has evolved several times. This begs the question: why be...

Backer Badge Funded